← All Matinas Biopharma Holdings, INC filings

Matinas Biopharma Holdings, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

AMEX

15 Apr 2025

MTNB

10-K: Matinas BioPharma Details Capital Structure, Outlines Strategic Focus in Annual Report

Matinas BioPharma's 10-K filing details its capital structure, strategic shift towards partnering for MAT2203, and ongoing efforts to explore strategic alternatives.

AMEX

27 Mar 2024

MTNB

Matinas Biopharma Holdings, INC

10-K: Matinas BioPharma Details Capital Structure and Anti-Takeover Measures in 10-K Filing

Matinas BioPharma's 10-K filing outlines the company's capital structure, including authorized common and preferred stock, and details anti-takeover provisions.